How hospital systems, PBMs, and self-insured employers can use IP intelligence to time generic switches and eliminate billions in avoidable […]
Patent Expiration Data: The Procurement Playbook That Cuts Your Drug Spend by 80% Read Post »
Darshan Kulkarni PharmD, MS, Esq. www.kulkarnilawfirm.com Introduction The intersection of intellectual property (IP) and artificial intelligence (AI) has triggered a
A complete guide for pharmaceutical executives, IP strategists, generic manufacturers, and investors navigating one of the world’s most distinctive patent
The UK Patent Box slashes the effective corporation tax rate on patented-drug profits from 25% to 10%. That 15-percentage-point gap
Patent Box Tax Strategy: The Definitive Guide to Pharma IP Tax Optimization Read Post »
Generic drug companies do not compete on science. They compete on timing, legal nerve, and an encyclopedic understanding of a
How 180 Days Can Make or Break a Generic Drug Launch: The ANDA Exclusivity Playbook Read Post »
The most sought-after scientists in biopharma rarely post their resumes to LinkedIn. They don’t have to. Their work announces them
Find Top Biopharma Talent Before Anyone Else: The Patent-to-Pipeline Hiring Playbook Read Post »
When a European patent dies — formally, irrevocably, at the hands of the European Patent Office’s Technical Board of Appeal
AURYXIA (ferric citrate) Keryx biopharms Patent: 8,093,423 Expiration: Apr 21, 2026 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of April 19, 2026 Read Post »
When Johnson & Johnson’s multiple myeloma franchise Darzalex (daratumumab) generated roughly $10 billion in global revenue in 2024, it stood
Sign in or create a free account to read this DrugPatentWatch article
